Chris Degnan, Chief Financial Officer at UroGen Pharma Ltd. (URGN), sold 2,203 shares at $16.85 ($37K) on 2025-10-08, disclosed to the SEC on 2025-10-09.
Open-market sale of $37k URGN by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| VRCA | BUY | 2018-08-15 | $45K | — | Filing → |